Chemical Name: 1-(5-(t-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea. Alternate Names: AC220
FLT3 inhibitor
Molekulargewicht:
560.67
Reinheit:
98% by HPLC NMR (Conforms)
Formulierung:
Off-whtie solid
CAS Nummer:
[950769-58-1]
Formel:
C29H32N6O4S
Anwendungsbeschreibung:
Quizartinib is a potent and selective inhibitor of FLT3 (Kd = 1.6nM, IC50 = 0.56 nM MV4-11 cells).1 It is in clinical trials for treatment of Acute Myelogenous Leukemia (AML).2,3 Quizartinib priming resulted in prevention of myelosuppression in mice treated with 5-FU and Gemcitabine.4 Quizartinib showed significant reversal of ABCG2-mediated multidrug resistance ( 3 µM) via antagonism of drug efflux function.5,6
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten